The largest database of trusted experimental protocols

Ish protease 2

Manufactured by Roche

ISH Protease 2 is a laboratory product manufactured by Roche. It is a protease enzyme used for sample preparation in in-situ hybridization (ISH) techniques.

Automatically generated - may contain errors

4 protocols using ish protease 2

1

In Situ Detection of EBV

Check if the same lab product or an alternative is used in the 5 most similar protocols
The status of EBV infection was assessed by an ISH detection for EBER on paraffin-embedded tissue sections using fluorescein-labeled oligonucleotide probes (INFROM EBER Probe, Ventana), as previously described [10 (link)]. The visualization system used was the Bench Mark XT with enzymatic digestion (ISH Protease 2, Ventana) and the iVIEW Blue v3 detection kit (Ventana). Appropriate positive and negative control sections were included for each run.
+ Open protocol
+ Expand
2

EBER Detection in Biopsy Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biopsy samples (4-μm thick) were mounted on glass slides to detect EBER using automated ISH (BENCHMARK, VENTANA MEDICAL SYSTEM, Oro Valley, AZ, USA), previously described21 (link). Briefly, tissue samples were treated with ISH protease 2 (catalog no. 780-4147; VENTANA MEDICAL SYSTEM) and labeled with an EBER-specific probe (catalog no. 780-2842; VENTANA MEDICAL SYSTEM), which was detected using the Inform Probes iView Blue V3 detection kit (VENTANA MEDICAL SYSTEM)21 (link). A sample was considered EBV (+) if definitive tumor cells were labeled with the EBER probe, and EBV (−) if the EBER-ISH was negative in tumor cells or positive only in bystander cells. The EBER staining patterns were interpreted by a hematopathologist who was blinded to the clinical outcomes of the patients. Histologic findings from a representative case is shown in Fig. 4.

Histologic examination of a monomorphic PTLD–DLBCL involving terminal ileum (A) hematoxylin and eosin, original magnification ×200, (B) tumor cells were negative for CD3, (C) while positive for CD20 and (D) EBER. PTLD post-transplantation proliferative disorder, DLBCL diffuse large B-cell lymphoma, EBER Epstein-Barr Virus-encoded small ribonucleic acid.

+ Open protocol
+ Expand
3

EBV Detection via EBER ISH in Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The status of EBV infection was assessed by ISH detection for EBER on paraffin-embedded tissue sections using fluorescein-labeled oligonucleotide probes (INFROM EBER Probe, Ventana), as previously described [11 (link)]. The visualization system used was the BenchMark XT with enzymatic digestion (ISH Protease 2, Ventana) and the iVIEW Blue v3 Detection Kit (Ventana). A known EBV-positive tumor was used as a positive control in each run. An appropriate negative control section was also included.
+ Open protocol
+ Expand
4

EBV Detection in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The presence of EBV in the cancer cells was assessed according to the protocol described in our previous study for EBV chromogenic in situ hybridization using an automatic staining device (Benchmark XT, Ventana, Tucson, AZ, USA) [11] . Briefly, 4-lm-thick sections were cut from representative blocks obtained from each patient, mounted onto coated slides, and dried at 74 °C for 30 min. After pretreatment with ISH protease 2 (Ventana) for 8 min at 37 °C, the slides were denatured at 85 °C for 12 min and hybridization was conducted at 57 °C for 1 h using EBV-encoded small RNA probes (INFORM, Ventana) that had been labeled with fluorescein. Detection was sequentially performed by applying mouse anti-fluorescein antibody and biotinylated goat antimouse antibody (iView blue; Ventana); counterstaining was performed using nuclear fast red. Strong staining in the nucleus was considered to indicate positivity, and the proportion of EBV-positive tumor cells was thereby evaluated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!